Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O R McIntyre

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Family Practice|September 1, 1989
Community screening for cervical cancer in New HampshireA J Dietrich, P Carney-Gersten, D W Holmes, et al.
Blood|July 1, 1979
Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGBJ B Harley, T F Pajak, O R McIntyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Mood and clinical status in patients with multiple myelomaP M Silberfarb, K M Anderson, A C Rundle, et al.
Haematology and Blood Transfusion|January 1, 1987
Therapeutic strategies in acute myelocytic leukemia: a status report of the experience of CALGB. Cancer and Leukemia Group BK R Rai, J Cuttner, J F Holland, et al.
Cancer Treatment Reports|August 1, 1979
Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNUR A Kyle, S Gailani, B R Seligman, et al.
Cancer Treatment Reports|April 1, 1984
Combined modality approach in the management of locally advanced head and neck cancerC T Coughlin, M Grace, J F O'Donnell, et al.
Medical and Pediatric Oncology|January 1, 1988
Mitoxantrone in relapsed or refractory acute nonlymphocytic leukemiaJ J Vredenburgh, O R McIntyre, G G Cornwell, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1988
Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myelomaO R McIntyre, M Tefft, K Propert, et al.
Blood|December 1, 1986
Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemiaJ D Griffin, R Davis, D A Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B studyM R Cooper, K Dear, O R McIntyre, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Family Practice|September 1, 1989
Community screening for cervical cancer in New HampshireA J Dietrich, P Carney-Gersten, D W Holmes, et al.
Blood|July 1, 1979
Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGBJ B Harley, T F Pajak, O R McIntyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Mood and clinical status in patients with multiple myelomaP M Silberfarb, K M Anderson, A C Rundle, et al.
Haematology and Blood Transfusion|January 1, 1987
Therapeutic strategies in acute myelocytic leukemia: a status report of the experience of CALGB. Cancer and Leukemia Group BK R Rai, J Cuttner, J F Holland, et al.
Cancer Treatment Reports|August 1, 1979
Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNUR A Kyle, S Gailani, B R Seligman, et al.
Cancer Treatment Reports|April 1, 1984
Combined modality approach in the management of locally advanced head and neck cancerC T Coughlin, M Grace, J F O'Donnell, et al.
Medical and Pediatric Oncology|January 1, 1988
Mitoxantrone in relapsed or refractory acute nonlymphocytic leukemiaJ J Vredenburgh, O R McIntyre, G G Cornwell, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1988
Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myelomaO R McIntyre, M Tefft, K Propert, et al.
Blood|December 1, 1986
Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemiaJ D Griffin, R Davis, D A Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B studyM R Cooper, K Dear, O R McIntyre, et al.
Pageof 9